Retour
Fourchette du Jour
17,21 €
17,88 €
Fourchette 52 Semaines
10,96 €
21,49 €
Volume
599 773
Moyenne 50J / 200J
19,13 €
/
16,82 €
Clôture Précédente
17,15 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -42,3 | 0,4 |
| P/B | 3,0 | 2,9 |
| ROE % | -6,3 | 3,7 |
| Net Margin % | -5,6 | 3,9 |
| Rev Growth 5Y % | 6,4 | 10,0 |
| D/E | 0,1 | 0,2 |
Objectif de Cours des Analystes
Hold
23,33 €
+32.9%
Low: 18,00 €
High: 26,00 €
BPA Prévisionnel
-0,07 €
CA Est.
430 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2028 |
0,70 €
0,69 € – 0,70 €
|
530 M | 1 |
| FY2027 |
0,28 €
0,26 € – 0,30 €
|
480 M | 4 |
| FY2026 |
-0,07 €
-0,07 € – -0,07 €
|
430 M | 4 |
Points Clés
Revenue grew 6,40% annually over 5 years — modest growth
Earnings declined -140,64% over the past year
Debt/Equity of 0,06 — conservative balance sheet
Generating 36,12M in free cash flow
PEG of 0,34 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 7,39%
Croissance
Revenue Growth (5Y)
6,40%
Revenue (1Y)13,79%
Earnings (1Y)-140,64%
FCF Growth (3Y)N/A
Qualité
Return on Equity
-6,27%
ROIC-4,88%
Net Margin-5,62%
Op. Margin-5,53%
Sécurité
Debt / Equity
0,06
Current Ratio2,86
Interest Coverage0,00
Valorisation
P/E Ratio
-42,29
P/B Ratio2,98
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 13,79% | Revenue Growth (3Y) | 16,40% |
| Earnings Growth (1Y) | -140,64% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 6,40% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 379,81M | Net Income (TTM) | -21,35M |
| ROE | -6,27% | ROA | -5,17% |
| Gross Margin | 66,99% | Operating Margin | -5,53% |
| Net Margin | -5,62% | Free Cash Flow (TTM) | 36,12M |
| ROIC | -4,88% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,06 | Current Ratio | 2,86 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -42,29 | P/B Ratio | 2,98 |
| P/S Ratio | 2,38 | PEG Ratio | 0,34 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 903,16M | Enterprise Value | 857,41M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 379,81M | 333,79M | 280,32M | 321,79M | 296,40M |
| Net Income | -21,35M | 52,55M | -190,28M | -76,61M | -30,66M |
| EPS (Diluted) | -0,40 | 0,93 | -3,54 | -1,44 | -0,59 |
| Gross Profit | 254,43M | 224,16M | 178,33M | 209,58M | 199,01M |
| Operating Income | -21,02M | 40,77M | -203,36M | -77,23M | -29,73M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 413,23M | 491,05M | 466,83M | 542,99M | 566,62M |
| Total Liabilities | 110,13M | 112,62M | 205,50M | 112,08M | 100,75M |
| Shareholders' Equity | 303,10M | 378,43M | 261,33M | 430,91M | 465,88M |
| Total Debt | 19,68M | 28,37M | 34,22M | 39,00M | 21,35M |
| Cash & Equivalents | 65,43M | 114,69M | 82,20M | 89,92M | 348,49M |
| Current Assets | 257,13M | 351,83M | 313,71M | 387,85M | 433,36M |
| Current Liabilities | 89,85M | 89,37M | 78,07M | 75,98M | 77,30M |